AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-169982445/dr-reddy-licenses-sinclair.html" title="Facts and information about Dr Reddy's licenses Sinclair's Sebclair in USA.(Dr. Reddy's Laboratories Ltd.)(Brief article)">Dr Reddy's licenses Sinclair's Sebclair in USA.(Dr. Reddy's Laboratories Ltd.)(Brief article)</a>
Close
Set up an RSS feed that alerts you when new articles from Pharma Marketletter are available.
Frequently asked questions about RSS feeds
Dr Reddy's licenses Sinclair's Sebclair in USA.(Dr. Reddy's Laboratories Ltd.)(Brief article)
Godalming, UK-based Sinclair Pharma has licensed the exclusive US rights on its seborrheic dermatitis product Sebclair to the US unit of Indian drug major Dr Reddy's. The latter will market the product under a new brand name through its new dermatology division. The agreement grants Dr Reddy's exclusivity in the USA for Sebclair and ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Novartis prevails in Lamisil patent dispute with Dr Reddy's.(Brief Article)
- Newspaper article from: Pharma Marketletter September 13, 2004 700+ words
...patent infringement law suit with India's Dr Reddy's Laboratories regarding the Swiss drug...antifungal agent Lamisil (terbinafine HCl). Dr Reddy's has withdrawn its challenge to a Lamisil...for the Southern District of New York, Dr Reddy's will not manufacture, use, sell...
- Dr Reddy's opens S African subsidiary.(Dr Reddy's Laboratories)(Brief Article)
- Newspaper article from: Pharma Marketletter November 17, 2003 700+ words
Indian drugmaker Dr Reddy's Laboratories says that it has launched a South African subsidiary, Dr Reddy's Laboratories Pvt Ltd, South Africa (Dr Reddy's SA). The unit has been established with Venturepharm Pvt Ltd, itself a subsidiary...
- Dr Reddy's revenues fall 8%, net plunges.(Dr Reddy's Laboratories )(Brief...
- Newspaper article from: Pharma Marketletter February 7, 2005 700+ words
...third fiscal quarter ended December 31, 2004, Indian drugmaker Dr Reddy's Laboratories posted an 8.0% decline in revenues to 4.70...presence in key markets are the pillars on which we are building Dr Reddy's of tomorrow."
- Dr Reddy's launches Nexret in India.(Dr Reddy's Laboratories)(Brief article)
- Newspaper article from: Pharma Marketletter May 4, 2009 700+ words
India drug major Dr Reddy's Laboratories has launched Nexret (tretinoin 0.04% & 0.1% as microspheres) on its domestic market. It marks the entry of Dr. Reddy's into the topical anti-acne segment, a commonly diagnosed condition...
- SCOLR and Dr Reddy's enter licensing deal.(SCOLR Pharma)(Dr Reddy's...
- Newspaper article from: Pharma Marketletter October 29, 2007 700+ words
...collaboration and license agreement with India-headquartered Dr Reddy's Laboratories. The parties will pursue the development...utilizing SCOLR's CDT technology. Under the terms of the deal, Dr Reddy's will be responsible for the development, manufacturing...
- Dr. Reddy's.(RX/GENERIC DRUGS--Profiles)(Dr. Reddy's Laboratories Ltd)(Brief...
- Magazine article from: Chain Drug Review September 17, 2007 700+ words
...704) 496-6070 www.drreddys.com Dr. Reddy's began generics operations in 2001...Canada) and the European Union. The Dr. Reddy's mission is two-fold: to provide...of finished dosages. Within the year Dr. Reddy's has successfully launched such products...
- Dr. Reddy. (Active Pharmaceuticals Ingredient Watch).(Dr. Reddy's...
- Magazine article from: Chemical Market Reporter February 4, 2002 700+ words
DR. REDDY'S Laboratories offered a voluntary retirement plan ended January 31 for permanent workers over age 40 or 10-year veterans...
- Dr Reddy's sees full-year sales climb 11%.(Dr Reddy's Laboratories)(Brief...
- Newspaper article from: Pharma Marketletter June 7, 2004 700+ words
India's Dr Reddy's Laboratories has posted revenues for the full year ending March 31 of 20 billion rupees ($442 million), marking solid 11...